Pharmacokinetic profiles of two tablet formulations of piroxicam

International Journal of Pharmaceutics

Volumn 295, Issue 1-2, 2005, Pages 129-134

  Rasetti Escargueil, C ^a   Grange V ^b  

^a Therapharm Recherches   (France)

^b Cephalon France   (France)

Author keywords

Bioequivalence; Freeze dried tablet; Healthy volunteers; Piroxicam

Indexed keywords

PIROXICAM; PROXALYOC;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; FREEZE DRYING; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET; TABLET FORMULATION;

EID: 17644384451     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.02.006     Document Type: Article

References (12)

1. G. Consoli, M. Covelli, L. Di Matteo, R. Marcolongo, G. Tirri, G. La Montagna, and V. Pipitone Piroxicam compresse sublinguali a rapida dissoluzione vs. naprossene nel trattamento dell'osteoartrosi riacutizzata [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial] Minerva Med. 85 1994 89 96
2. X. Deroubaix, A. Stockis, A.M. Allemon, E. Lebacq, D. Acerbi, and P. Ventura Oral bioavailability of CHF1194, an inclusion complex of piroxicam and β-cyclodextrin, in healthy subjects under single dose and steady state conditions Eur. J. Clin. Pharmacol. 47 1995 531 536
3. G. Dolci, M. Ripari, L. Pacifici, and A. Umile Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain Minerva Stomatol. 42 1993 235 241
4. T.T. Jaccard, and J. Leyder Une nouvelle forme galénique: le lyoc [A new galenic form: lyoc] Ann. Pharm. Fr. 43 1985 123 131
5. C.R. Lee, and J.A. Balfour Piroxicam-β-cyclodextrin a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states Drugs 48 1994 907 929
6. J. Leyder, and T. Nguyen Le lyophilisat oral: une innovation galénique [The oral lyophilisate: a galenic innovation] Moniteur Hospitalier 22 1990 4 8
7. B.A. Mueller, D.K. Rex, N. Figueroa, P. Greene, and D.C. Brater A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation Pharmacotherapy 12 1992 93 97
8. D.A. Piscitelli, S. Bigora, C. Propst, S. Goskonda, P. Schwartz, L.J. Lesko, L. Augsburger, and D. Young The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules Pharm. Dev. Technol. 3 1998 443 452
9. F. Ronca, L. Palmieri, and G. Ronca Effetto della formulazione e della via di somministrazione sulla velocità di assorbimento del piroxicam [Effect of the formulation and the route of administration on the rate of absorption of piroxicam] Basi Raz. Ter. 24 1994 1 6
10. E. Selcuk, M. Gomel, S. Apaydin, T. Kose, and I. Tuglular The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium Int. J. Clin. Pharmacol. Ther. Res. 18 1998 9 21
11. T.F. Woolf, and L.L. Radulovic Oxicams: metabolic disposition in man and animals Drug Metab. Rev. 21 1989 255 276
12. H. Zhang, J. Zhang, and J.B. Streisand Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications Clin. Pharmacokinet. 41 2002 661 680